Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (14)

2022

  1. Association between Circulating Levels of 25-Hydroxyvitamin D3 and Matrix Metalloproteinase-10 (MMP-10) in Patients with Type 2 Diabetes

    Nutrients, Vol. 14, Núm. 17

  2. Time to Consider the “Exposome Hypothesis” in the Development of the Obesity Pandemic

    Nutrients, Vol. 14, Núm. 8

2020

  1. A Spanish consensus on the use of safinamide for parkinson’s disease in clinical practice

    Brain Sciences, Vol. 10, Núm. 3

  2. Elevated circulating metalloproteinase 7 predicts recurrent cardiovascular events in patients with carotid stenosis: A prospective cohort study

    BMC Cardiovascular Disorders, Vol. 20, Núm. 1

  3. Erratum: A Spanish consensus on the use of safinamide for parkinson’s disease in clinical practice. (Brain sci. (2020) 10, 176)

    Brain Sciences

  4. MMP-10 is Increased in Early Stage Diabetic Kidney Disease and can be Reduced by Renin-Angiotensin System Blockade

    Scientific Reports, Vol. 10, Núm. 1

2017

  1. Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update

    The Lancet Neurology, Vol. 16, Núm. 3, pp. 238-250

2016

  1. DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2R1441G Parkinson's disease

    Movement Disorders, Vol. 31, Núm. 3, pp. 335-343

2013

  1. Bilateral stimulation of the subthalamic nucleus has differential effects on reactive and proactive inhibition and conflict-induced slowing in Parkinson's disease

    Experimental Brain Research, Vol. 226, Núm. 3, pp. 451-462

2011

  1. LINGO1 gene analysis in Parkinson's disease phenotypes

    Movement Disorders, Vol. 26, Núm. 4, pp. 722-727

2010

  1. Goal-directed and habitual control in the basal ganglia: Implications for Parkinson's disease

    Nature Reviews Neuroscience, Vol. 11, Núm. 11, pp. 760-772

  2. Missing pieces in the Parkinson's disease puzzle

    Nature Medicine, Vol. 16, Núm. 6, pp. 653-661

  3. Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An 18F-DOPA and 11C-DTBZ PET study

    Neurobiology of Disease, Vol. 38, Núm. 3, pp. 456-463

2009

  1. Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms

    The Lancet Neurology, Vol. 8, Núm. 12, pp. 1128-1139